| Literature DB >> 34590422 |
Anne-Cecile Ezanno1, Anne-Claire Fougerousse2, Philippe Guillem3.
Abstract
Entities:
Keywords: axillary; hidradenitis suppurativa; negative-pressure wound therapy; wide surgical excision
Mesh:
Year: 2021 PMID: 34590422 PMCID: PMC9013599 DOI: 10.1111/iwj.13678
Source DB: PubMed Journal: Int Wound J ISSN: 1742-4801 Impact factor: 3.099
Satisfaction study
| Not at all ( | Not totally ( | Moderately satisfied ( | Partially satisfied ( | Completely satisfied ( | |
|---|---|---|---|---|---|
| 1‐Are you satisfied concerning shoulder mobility? | 0 | 0 | 3 (15.8%) | 7 (36.8) | 9 (47.4) |
| 2‐Are you satisfied concerning aesthetic results? | 1 (5.3%) | 1 (5.3%) | 3 (15.8%) | 8 (42.1%) | 6 (31.5%) |
| 3‐Are you satisfied concerning NPWT? | 1 (5.3)% | 0 | 2 (10.5%) | 2 (10.5%) | 14 (73.7%) |
| 4‐Would you do this surgery with NPWT again? | 4 (21%) | 1 (5.3%) | 2 (10.5%) | 4 (21%) | 8 (42.1%) |
| 5‐Would you recommend the surgery to another HS patient? | 2 (10.5%) | 0 | 2 (10.5%) | 3 (15.8%) | 12 (63.2%) |
Abbreviations: HS, hidradenitis suppurativa; NPWT, negative‐pressure wound therapy.
Summary of articles on surgical interventions in patients with axillary hydratenitis suppuritiva published since 2010
| Study, year | No. of patients | Closure type | Length of surgery (min) | Excised area (cm2) | Length of hospitalisation (day) | Length of healing (days) | Complication (n; %) | Recurrence rate (%) | Length follow up (month) |
|---|---|---|---|---|---|---|---|---|---|
| Busnardo et al (2011) | 12 | Flap | ND | ND | ND | ND | ND | 38.8% | 6 months |
| Afsharfard et al (2020) | 13 | STSG and flap | ND | ND | ND | ND | ND | 0 | 1 year |
| Wormald et al (2014) | 27 | Graft and flap | 146.5 ± 69.8 | ND | 5.6 ± 2.9 | 70.7 ± 89.6 | ND | 3.7% | 1 year |
| Ortiz et al (2010) | 16 | Thoracodorsal artery perforator flap | ND | ND | ND | ND | ND | 0 | ND |
| Marchesi et al (2018) | 17 | Thoracodorsal artery perforator flap | 151 ± 31 | 94.5 ± 38 | 1 to 5 | 20 ± 9 | N = 6; 35% | ND | ND |
| Pearce et al (2017) | 7 | NPWT + STSG | ND | 335 | 8.8 ± 4 | 38.7 ± 15,3 | ND | ND | 1 months |
| Elgohary et al (2018) | 20 | Thoracodorsal artery perforator flap | 210 ± 25 | Range 96 to 204 | 6 ± 3 | ND | N = 7; 35% | ND | 30 months ± 5.2 |
| Elboraey et al (2019) | 6 | Propeller flap | ND | Range 66 to 252 | 4 | ND | N = 2; 33% | 0 | 10 months mean |
| Ching et al (2017) | 4 | Transposition flap | ND | ND | ND | ND | N = 1; 25% | 0 | 18 months |
| Wu et al (2020) | 34 | Rotation flap | 4 ± 16 | 84 | 0 | ND | N = 13; 25% | 10% | 32 months |
| Gonzaga et al (2013) | 4 | Graft with bilayer dermal regeneration | ND | Range 200 to 300 | ND | ND | N = 1; 25% | 0 | 23 months |
| Hallock et al (2013) | 2 | Thoracodorsal artery perforator based V‐Y advancement | ND | 90 | ND | 45,5 | 1 (minor) | 0 | 9.5 months |
| Varkarakis et al (2010) | 15 | Rotation flap | ND | 212 | ND | ND | N = 4; 26.6% | 0 | 12 months |
| Nail‐Barthelemy et al (2019) | 13 | Perforator flap | 76.2 ± 18.8 | 58 ± 31.5 | 5.1 ± 3.1 | 20.5 ± 13.5 | N = 6; 46% | 0 | 9 months |
| Calibre et al (2013) | 5 | Skin grafting + NPWT | ND | ND | ND | 34 (20–43) | 0 | ND | ND |
| Jandali et al (2013) | 9 | Thoracodorsal artery perforator | ND | 74 | ND | ND | N = 2; 22;% | 11.1% | 20 months |
|
|
|
|
|
|
|
|
|
Abbreviations: NPWT, negative‐pressure wound therapy; STSG, split‐thickness skin graft.
Patients demographics
| Number of patients ( | Mean ± SD | Ranges | ||
|---|---|---|---|---|
| Patients | 20 | |||
| Men | 8 (40%) | |||
| Women | 12 (60%) | |||
| Age (years) | 27.1 ± 7.7 | 15 to 40 | ||
| BMI (kg/m2) | 28.2 ± 5 | 20.3 to 42.5 | ||
| Tabaco (yes) | 11 (55%) | |||
| ASA score | ||||
| ASA 1 | 9 (45%) | |||
| ASA 2 | 11 (55%) | |||
| Medical treatments | ||||
| Systemic antibiotics | 15 (75%) | |||
| Anti‐TNF | 2 (5%) | |||
| Disease duration years | 7.1 ± 6.7 | 1 to 20 | ||
| Age of illness onset | 19.9 ± 5.7 | 11 to 37 | ||
| Patients with unilateral excision | 4 (20%) | |||
| Patient with bilateral excision | 16 (80%) | |||
| Size of the operated axilla | 35 | |||
| Left | 17 (48.6%) | |||
| Right | 18 (51.4%) | |||
| Hurley's stage | ||||
| Stage 2 | 10 (50%) | |||
| Stage 3 | 10 (50%) | |||
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; TNF, tumour necrosis factor.
Results
| Number of patients ( | Mean ± SD | Extremes | ||
|---|---|---|---|---|
| Excised area (cm2) | 46.6 ± 43 | 10 to 195 | ||
| Operative time (minutes) | 39.4 ± 13 | 20 to 64 | ||
| Length of hospitalisation (days) | 3 ± 0.2 | 3 to 4 | ||
| Length of NPWT healing (days) | 18.5 ± 9 | 5 to 39 | ||
| Length of complete healing | 115 ± 85 | 21 to 407 | ||
| Complication | 5 (25%) | |||
| Infection | 2 (5.7%) | |||
| Bleeding | 0 | |||
| Pain | 4 (11.4%) | |||
| Loss of mobility | 1 (2.8%) | |||
| Length of follow‐up (days) | 375.5 ± 226.3 | 37 to 764 | ||
| Recurrences of HS | 1 (5%) | |||
Abbreviations: HS, hidradenitis suppurativa; NPWT, negative‐pressure wound therapy.